Elanco Animal Health Incorporated (ELAN) is listed on NYSE in Pharmaceutical Stocks. It is $24.11, -1.55%, with a $12.0B market cap. RSI is 48.8, neutral. The latest reported quarter beat estimates. Insiders were net buyers across the listed trades.
Technical Analysis
RSI (14) 48.8 Neutral
Market Cap $12.0B
Volume 2.8M
Fundamentals — 10-Q Q2 2026
Revenue $2.7B
Net Income $111.0M
EPS $0.22
Gross Margin 57.8%
Net Margin 4.1%
Debt / Equity 0.6x
P/E Ratio 109.6x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Kurzius Lawrence Erik | Insider | Buy | 40,000 | $23.40 | $935,920 | 2026 Aug 20 |
| O'neill Shiv | GC AND CORP SEC | Buy | 3,998 | $23.58 | $94,273 | 2026 Aug 18 |
| Harrington Michael J | Insider | Buy | 5,000 | $21.82 | $109,100 | 2026 Aug 12 |
| Vanhimbergen Robert M | EVP and CFO | Buy | 4,200 | $23.08 | $96,926 | 2026 Aug 7 |
| Herendeen Paul | Insider | Buy | 10,000 | $23.68 | $236,850 | 2026 Aug 7 |
| Modi Rajeev A. | Insider | Buy | 4,911 | $20.35 | $99,939 | 2026 May 15 |
| Simmons Jeffrey N | PRESIDENT, CEO AND DIRECTOR | Buy | 4,971 | $20.09 | $99,843 | 2026 May 15 |
| Kurzius Lawrence Erik | Director | Buy | 10,000 | $21.30 | $213,000 | 2025 Dec 12 |
| VanHimbergen Robert M | EVP and CFO | Buy | 6,950 | $21.64 | $150,398 | 2025 Dec 11 |
| Simmons Jeffrey N | PRESIDENT, CEO AND DIRECTOR | Buy | 22,000 | $21.75 | $478,500 | 2025 Dec 11 |
| Modi Rajeev A. | Officer | Buy | 4,500 | $21.33 | $95,985 | 2025 Dec 11 |
| Kurzius Lawrence Erik | Director | Buy | 20,000 | $10.55 | $211,000 | 2025 Mar 11 |
| Hoover R David | Director | Buy | 25,000 | $10.90 | $272,500 | 2025 Mar 5 |
| Harrington Michael J | Director | Buy | 3,500 | $14.85 | $51,975 | 2024 Aug 22 |
| Simmons Jeffrey N | PRESIDENT, CEO AND DIRECTOR | Buy | 100,000 | $13.01 | $1.3M | 2024 Aug 12 |
| Doyle William F | Director | Buy | 15,000 | $16.98 | $254,700 | 2024 May 21 |
| Harrington Michael J | Director | Buy | 3,100 | $16.29 | $50,499 | 2024 Mar 8 |
| Doyle William F | Director | Buy | 15,000 | $16.30 | $244,500 | 2024 Mar 8 |
| Hoover R David | Director | Buy | 20,000 | $16.14 | $322,800 | 2024 Mar 6 |
| Hoover R David | Director | Buy | 10,000 | $9.51 | $95,050 | 2023 Mar 14 |
Other Pharmaceutical Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $1,173.34 | 46.3 | $1.1T |
| | $268.01 | 58.6 | $645.9B |
| | $148.31 | 64.1 | $365.9B |
| | $34.17 | 49.9 | $2.5B |
| | $61.02 | 60.3 | $10.1B |
| | $84.85 | 71.8 | $9.0B |
| | $47.41 | 37.2 | $8.0B |
| | $345.04 | 48.5 | $9.6B |
Take ELAN further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put ELAN in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Elanco Animal Health Incorporated next reports.
Set alerts on ELAN
Get notified when Elanco Animal Health Incorporated hits your price targets or technical conditions are met.
Get Started Free